Huo D - Search Results

1

Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Cohen EE, Kane MA, List MA, Brockstein BE, Mehrotra B, Huo D, Mauer AM, Pierce C, Dekker A, Vokes EE. Cohen EE, et al. Among authors: huo d. Clin Cancer Res. 2005 Dec 1;11(23):8418-24. doi: 10.1158/1078-0432.CCR-05-1247. Clin Cancer Res. 2005. PMID: 16322304 Clinical Trial.

2

Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.

Hoffman PC, Cohen EE, Masters GA, Haraf DJ, Mauer AM, Rudin CM, Krauss SA, Huo D, Vokes EE. Hoffman PC, et al. Among authors: huo d. Lung Cancer. 2002 Oct;38(1):65-71. doi: 10.1016/s0169-5002(02)00144-7. Lung Cancer. 2002. PMID: 12367795 Clinical Trial.

3

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.

Cohen EE, Rosen F, Stadler WM, Recant W, Stenson K, Huo D, Vokes EE. Cohen EE, et al. Among authors: huo d. J Clin Oncol. 2003 May 15;21(10):1980-7. doi: 10.1200/JCO.2003.10.051. J Clin Oncol. 2003. PMID: 12743152 Clinical Trial.

4

A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis.

Kane S, Huo D, Magnanti K. Kane S, et al. Among authors: huo d. Clin Gastroenterol Hepatol. 2003 May;1(3):170-3. doi: 10.1053/cgh.2003.50025. Clin Gastroenterol Hepatol. 2003. PMID: 15017487 Clinical Trial.

5

A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.

Odenike OM, Sobecks RM, Janisch L, Huo D, Zimmerman TM, Daugherty CK, Ratain MJ, Larson RA. Odenike OM, et al. Among authors: huo d. Cancer Chemother Pharmacol. 2004 Dec;54(6):553-61. doi: 10.1007/s00280-004-0857-3. Epub 2004 Sep 2. Cancer Chemother Pharmacol. 2004. PMID: 15349753 Clinical Trial.

6

Planned post-chemoradiation neck dissection: significance of radiation dose.

Stenson KM, Huo D, Blair E, Cohen EE, Argiris A, Haraf DJ, Vokes EE. Stenson KM, et al. Among authors: huo d. Laryngoscope. 2006 Jan;116(1):33-6. doi: 10.1097/01.mlg.0000185846.27617.fe. Laryngoscope. 2006. PMID: 16481805

7

Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer.

Jin JO, Lehmann J, Taxy J, Huo D, Stöckle M, Vogelzang NJ, Steinberg G, Stadler WM. Jin JO, et al. Among authors: huo d. Clin Genitourin Cancer. 2006 Sep;5(2):150-4. doi: 10.3816/CGC.2006.n.032. Clin Genitourin Cancer. 2006. PMID: 17026804 Clinical Trial.

8

Complementary and alternative medicine use among breast cancer survivors.

Matthews AK, Sellergren SA, Huo D, List M, Fleming G. Matthews AK, et al. Among authors: huo d. J Altern Complement Med. 2007 Jun;13(5):555-62. doi: 10.1089/acm.2007.03-9040. J Altern Complement Med. 2007. PMID: 17604560

9

Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia.

Odenike OM, Alkan S, Sher D, Godwin JE, Huo D, Brandt SJ, Green M, Xie J, Zhang Y, Vesole DH, Stiff P, Wright J, Larson RA, Stock W. Odenike OM, et al. Among authors: huo d. Clin Cancer Res. 2008 Nov 1;14(21):7095-101. doi: 10.1158/1078-0432.CCR-08-1007. Clin Cancer Res. 2008. PMID: 18981008 Free PMC article. Clinical Trial.

10

Advances in breast cancer: pathways to personalized medicine.

Olopade OI, Grushko TA, Nanda R, Huo D. Olopade OI, et al. Among authors: huo d. Clin Cancer Res. 2008 Dec 15;14(24):7988-99. doi: 10.1158/1078-0432.CCR-08-1211. Clin Cancer Res. 2008. PMID: 19088015 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,024 results

Search Page

Filters